Resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with high-risk melanoma von Sabado, Rachel Lubong, Pavlick, Anna, Gnjatic, Sacha, Cruz, Crystal M, Vengco, Isabelita, Hasan, Farah, Spadaccia, Meredith, Darvishian, Farbod, Chiriboga, Luis, Holman, Rose Marie, Escalon, Juliet, Muren, Caroline, Escano, Crystal, Yepes, Ethel, Sharpe, Dunbar, Vasilakos, John P, Rolnitzsky, Linda, Goldberg, Judith, Mandeli, John, Adams, Sylvia, Jungbluth, Achim, Pan, Linda, Venhaus, Ralph, Ott, Patrick A, Bhardwaj, Nina

Volltext

Phase II study of low-dose cyclophosphamide and ipilimumab in metastatic melanoma von Pavlick, Anna C., Chandra, Sunandana, Stein, Claire, Madden, Kathleen M., Kannan, Rajni, Escano, Crystal, Muren, Caroline, Yepes, Ethel, Sabado, Rachel Lubong, Bhardwaj, Nina

Volltext

Phase I/II study of the TLR3 agonist poly-ICLC as an adjuvant for NY-ESO-1 protein vaccination with or without Montanide ISA-51 vg in patients with melanoma von Sabado, Rachel Lubong, Pavlick, Anna C., Gnjatic, Sacha, Ott, Patrick Alexander, Hasan, Farah, Spadaccia, Meredith, Vengco, Isabelita, Holman, Rose Marie, Muren, Caroline, Escano, Crystal, Yepes, Ethel, Stein, Claire, Jungbluth, Achim A, Pan, Linda S., Venhaus, Ralph Rudolph, Bhardwaj, Nina

Volltext

Poly-ICLC as an adjuvant for NY-ESO-1 protein vaccination with or without Montanide ISA-51 VG in patients with melanoma von Sabado, Rachel Lubong, Pavlick, Anna C., Gnjatic, Sacha, Hasan, Farah, Spadaccia, Meredith, Oner, Bike Su, Dong, Hanqing, Holman, Rose Marie, Vengco, Isabelita, Muren, Caroline, Escano, Crystal, Yepes, Ethel, Stein, Claire, Jungbluth, Achim A, Pan, Linda S., Venhaus, Ralph Rudolph, Salazar, Andres M., Ott, Patrick Alexander, Bhardwaj, Nina

Volltext

Phase I/II study of resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with melanoma von Sabado, Rachel Lubong, Pavlick, Anna C., Gnjatic, Sacha, Cruz, Crystal M, Vengco, Isabelita, Hasan, Farah, Darvishian, Farbod, Chiriboga, Luis, Holman, Rose Marie, Escalon, Juliet, Muren, Caroline, Escano, Crystal, Yepes, Ethel, Sharpe, Dunbar, Adams, Sylvia, Ott, Patrick Alexander, Jungbluth, Achim A, Pan, Linda S., Venhaus, Ralph Rudolph, Bhardwaj, Nina

Volltext

Phase I/II study of resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with melanoma von Sabado, Rachel Lubong, Pavlick, Anna C., Gnjatic, Sacha, Cruz, Crystal M, Vengco, Isabelita, Hasan, Farah, Darvishian, Farbod, Chiriboga, Luis, Holman, Rose Marie, Escalon, Juliet, Muren, Caroline, Escano, Crystal, Yepes, Ethel, Sharpe, Dunbar, Adams, Sylvia, Ott, Patrick Alexander, Jungbluth, Achim A, Pan, Linda S., Venhaus, Ralph Rudolph, Bhardwaj, Nina

Volltext

Phase I/II study of Resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with melanoma von Sabado, Rachel L, Pavlick, Anna, Gnjatic, Sacha, Cruz, Crystal, Vengco, Isabelita, Hasan, Farah, Darvishian, Farbod, Chiriboga, Luis, Holman, Rose Marie, Escalon, Juliet, Muren, Caroline, Escano, Crystal, Yepes, Ethel, Sharpe, Dunbar, Adams, Sylvia, Ott, Patrick, Jungbluth, Achim, Pan, Linda, Venhaus, Ralph, Bhardwaj, Nina

Volltext